The norepinephrine transporter (NET) is one of the major targets in neuropsychiatric and neurodegenerative diseases like attention deficit hyperactivity disorder (ADHD), depression, Alzheimer’s disease (AD), Parkinson’s disease (PD) and substance abuse [1]. The gene discussed is SLC6A2; the disease is Parkinson disease.